Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Concepción Fernández-Rodríguez"'
Autor:
Concepción Fernández-Rodríguez, Laura Serrato Romero, Sandra Soriano Moreno, Marcelino Cuesta
Publikováno v:
Psicología Educativa: Revista de los Psicólogos de la Educación, Vol 30, Iss 2, Pp 75-84 (2024)
Background: Evidence indicates an increasing prevalence of psychological issues among university students, exacerbated by COVID-19. However, conclusive data on the situation in Spanish universities is lacking. Objective: This study explores academic,
Externí odkaz:
https://doaj.org/article/0df04b2dc7b249b2b4d0cd91212bb297
Autor:
Concepción Fernández-Rodríguez, Dolores Paz-Caballero, Sonia González-Fernández, Marino Pérez-Álvarez
Publikováno v:
Frontiers in Psychology, Vol 9 (2018)
Background: From a contextual transdiagnostic approach, this study focuses on the importance of the processes of Experiential Avoidance and Activation in explaining and treating psychological problems. There exists widespread empirical evidence to su
Externí odkaz:
https://doaj.org/article/226e22b59f7242cfa183613613d5134b
Autor:
Juan Jose Rodríguez-Sevilla, Concepción Fernández-Rodríguez, Leyre Bento, Ramón Diez-Feijóo, Sergio Pinzón, Joan Gibert, Lierni Fernández-Ibarrondo, Marta Lafuente, Ana Ferrer, Blanca Sánchez-González, Eva Gimeno, Juan Sainz, Rafael Ramos, Juan F. García, Lluis Colomo, Beatriz Bellosillo, Antonio Gutiérrez, Antonio Salar
Publikováno v:
Blood Advances. 7:1606-1614
Several clinical risk models have been proposed to predict the outcome of follicular lymphoma (FL). The development of next-generation sequencing technologies has allowed the integration of somatic gene mutations into clinical scores to build genotyp
Autor:
Ramón Diez-Feijóo, Concepción Fernández-Rodríguez, Marta Lafuente, Nieves García-Gisbert, Ana Ferrer, Luis Colomo, Marta Salido, Antonio Salar
Publikováno v:
Blood Advances. 7:162-166
Autor:
Nieves Garcia-Gisbert, Leonor Arenillas, David Roman-Bravo, Juan Jose Rodriguez-Sevilla, Concepción Fernández-Rodríguez, Sara Garcia-Avila, Patricia Velez, Joan Gibert, Lierni Fernández-Ibarrondo, Antonio Salar, Lourdes Florensa, Beatriz Bellosillo, Ana Ferrer, Xavier Calvo
Publikováno v:
Leukemia. 36:2922-2926
Autor:
Joana, Vidal, Maria Concepción, Fernández-Rodríguez, David, Casadevall, Pilar, Garcia-Alfonso, David, Páez, Marta, Guix, Vicente, Alonso, María Teresa, Cano, Cristina, Santos, Gema, Durán, Elena, Élez, Jose Luis, Manzano, Rocio, Garcia-Carbonero, Reyes, Ferreiro-Monteagudo, Ferran, Losa, Estela, Pineda, Javier, Sastre, Fernando, Rivera, Beatriz, Bellosillo, Josep, Tabernero, Enrique, Aranda, Ramon, Salazar, Clara, Montagut
Publikováno v:
Clinical Cancer Research. 29:379-388
Purpose: Chemotherapy plus anti-EGFR is standard first-line therapy in RAS wild-type (wt) metastatic colorectal cancer (mCRC), but biomarkers of early response are clinically needed. We aimed to define the utility of ctDNA to assess early response in
Publikováno v:
R.E.M.A. Revista electrónica de metodología aplicada. 24:60-81
Las creencias acerca de los trastornos psicológicos pueden condicionar la forma de abordarlos. Por esto, el objetivo de esta investigación es crear y validar un cuestionario que evalúe cómo entienden y describen los trastornos psicológicos los e
Autor:
Xavier Calvo, David Roman-Bravo, Nieves Garcia-Gisbert, Juan Jose Rodriguez-Sevilla, Sara Garcia-Avila, Lourdes Florensa, Joan Gibert, Concepción Fernández-Rodríguez, Marta Salido, Anna Puiggros, Blanca Espinet, Luis Colomo, Beatriz Bellosillo, Ana Ferrer, Leonor Arenillas
Publikováno v:
Blood Advances. 6:3921-3931
Patients with oligomonocytic chronic myelomonocytic leukemia (OM-CMML) are currently classified according to the 2017 World Health Organization myelodysplastic syndromes classification. However, recent data support considering OM-CMML as a specific s
Autor:
Clara Montagut, Ramon Salazar, Enrique Aranda, Josep Tabernero, Beatriz Bellosillo, Fernando Rivera, Javier Sastre, Estela Pineda, Ferran Losa, Reyes Ferreiro, Rocío Garcia-Carbonero, José Luís Manzano, Elena Elez, Gema Durán, Cristina Santos, Maria Teresa Cano, Vicente Alonso, Marta Guix, David Páez, Pilar García-Alfonso, David Casadevall, Maria Concepción Fernández-Rodríguez, Joana Vidal
Purpose:Chemotherapy plus anti-EGFR is standard first-line therapy in RAS wild-type (wt) metastatic colorectal cancer (mCRC), but biomarkers of early response are clinically needed. We aimed to define the utility of ctDNA to assess early response in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed11c20d1556270e0bfe4b1c0086745
https://doi.org/10.1158/1078-0432.c.6532748.v1
https://doi.org/10.1158/1078-0432.c.6532748.v1
Autor:
Clara Montagut, Ramon Salazar, Enrique Aranda, Josep Tabernero, Beatriz Bellosillo, Fernando Rivera, Javier Sastre, Estela Pineda, Ferran Losa, Reyes Ferreiro, Rocío Garcia-Carbonero, José Luís Manzano, Elena Elez, Gema Durán, Cristina Santos, Maria Teresa Cano, Vicente Alonso, Marta Guix, David Páez, Pilar García-Alfonso, David Casadevall, Maria Concepción Fernández-Rodríguez, Joana Vidal
Supplementary Tables 1-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62f5de4d541efee4733f8c21aaea3489
https://doi.org/10.1158/1078-0432.22488512.v1
https://doi.org/10.1158/1078-0432.22488512.v1